Chiltern is a leading, global contract research organisation (“CRO”). The business offers a broad range of clinical CRO services for the pharmaceutical, biotech and medical device industries across a wide spectrum of therapeutic areas. The business serves its international client base from its office network across 35 countries. The CRO market has strong medium-term growth characteristics driven by: a continued increase in R&D spend by the biopharma industry; the growing worldwide regulatory burden associated with new drug applications; and, the continued trend to outsource CRO activities.
Kester Capital sold Chiltern in December 2013, generating a 2.2x return for Kester Capital funds.
www.chiltern.com
Member count: 5001-10000
Founded date: 1982
Investors 1
| Date | Name | Website |
| - | Kester Cap... | kestercapi... |
Mentions in press and media 23
| Date | Title | Description | Category | Author | Source |
| 21.08.2018 | Global CRO... | The report attributed the anti... | - | - | medcitynew... |
| 31.07.2017 | Term Sheet... | GOING DIRECT I’m back! Huge t... | - | - | fortune.co... |
| 10.11.2015 | Chiltern F... | The Michelin-starred head ... | - | - | cityam.com... |
| 04.08.2005 | EDC – perc... | Despite potential benefits off... | - | - | realwire.c... |
| 08.02.2005 | Chiltern m... | Chiltern International is to t... | - | - | realwire.c... |
| 02.02.2005 | Shaking of... | Despite a slowing in growth ov... | - | - | realwire.c... |
| 26.01.2005 | Chiltern l... | Leading clinical research orga... | - | - | realwire.c... |
| 01.12.2004 | India goes... | The Indian pharmaceutical indu... | - | - | realwire.c... |
| 25.10.2004 | Landmark g... | Leading independent CRO, Chilt... | - | - | realwire.c... |
| 14.10.2004 | Chiltern p... | Chiltern International clinica... | - | - | realwire.c... |
Show more